Clinical trials sponsored by Shanghai Junshi Bioscience Co., Ltd.

Phase breakdown

Conditions studied

Recruiting trials led by Shanghai Junshi Bioscience Co., Ltd.

• A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies
  NCT06839105 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 13 locations
• A Phase 2 Study Evaluating the Safety and Efficacy of JS207 With or Without JS015 in Combination With Chemotherapy in Patients With Colorectal Cancer
  NCT06885385 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia
  NCT05621070 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
  NCT06924606 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 18 locations
• JS207 Combination Therapy in Triple-negative Breast Cancer
  NCT07045311 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 22 locations
• JS212 Combination Therapies in Metastatic Colorectal Cancer
  NCT07503756 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
  NCT06095583 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 76 locations
• Phase II Clinical Study of JS207 (PD-1/VEGF Bispecific Antibody) Combination Therapies in Patients With Driver Gene-Positive, Advanced Non-Small Cell Lung Cancer After Failure of TKI Therapy
  NCT06868836 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

How many trials is Shanghai Junshi Bioscience Co., Ltd. recruiting for?

Shanghai Junshi Bioscience Co., Ltd. is the lead sponsor of 8 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.